MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by BARTELS-BERNAL, E.
Right arrow Articles by CHANG, H. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by BARTELS-BERNAL, E.
Right arrow Articles by CHANG, H. W.

Molecular Pharmacology, Vol 12, 813-819, Copyright © 1976 by the American Society for Pharmacology and Experimental Therapeutics

A Membrane Activation Cycle Induced by Sulfhydryl Reagents after Affinity Labeling of the Acetylcholine Receptor of Electroplax

EVA BARTELS-BERNAL 1, TERRONE L. ROSENBERRY 1, and HAI WON CHANG 1

1 Departments of Biochemistry and Neurology, College of Physicians and Surgeons, Columbia University, New York, New York 10032

Acetylcholine receptors in the innervated membrane of an electroplax cell from the electric eel Electrophorus electricus may be affinity-labeled, after disulfide reduction, by a variety of sulfhydryl alkylating and acylating agents. The conductance state of a cell after this receptor modification remains under receptor control but is extremely sensitive both to the structure of the affinity reagent and, frequently, to the concentration of the reagent during modification. When the affinity reagents 3-(agr-bromomethyl)-3'-[agr-(trimethylammonium)methyl]azobenzene bromide or 4-(4'-nitrophenoxycarbonyl)-phenyltrimethylammonium iodide are used in low concentration to label the receptor in situ, subsequent sequential applications of disulfides and dithiothreitol give rise to cycles of repolarization and depolarization of the innervated membrane. Since other mild oxidizing agents cannot substitute for disulfides in this activation cycle, it is concluded that the activation cycle arises from the reversible formation of a mixed disulfide on the receptor. This mixed disulfide probably involves the remaining sulfhydryl group near the acetylcholine binding site, which is formed by the initial disulfide reduction but not labeled by the affinity reagents. The membrane responses to these chemical manipulations of the receptor in situ suggest useful criteria for evaluating the similarity of an isolated receptor after reconstitution into black lipid membranes to the receptor in its native state.

Note:
ACKNOWLEDGMENTS We thank Dr. David Nachmansohn for his encouragement of this work. We also thank Drs. B. Erlanger, A. Karlin, and H. Mautner and the Squibb Institute for Medical Research for their generous gifts of the chemicals indicated under METHODS.

Submitted on December 15, 1975
Accepted on May 5, 1976







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1976 by the American Society for Pharmacology and Experimental Therapeutics